Trump diagnosed with chronic venous insufficiency following leg swelling
Betsy Klein
, CNN
US President Donald Trump has been diagnosed with chronic venous insufficiency. File photo.
Photo:
Andrew Caballero-Reynolds / AFP
US President Donald Trump was examined for swelling in his legs and has been diagnosed with chronic venous insufficiency, the White House announced Thursday.
Trump, 79, underwent a "comprehensive examination, including diagnostic vascular studies" with the White House Medical Unit, press secretary Karoline Leavitt said, reading a note from the president's physician, Capt Sean Barbabella.
Barbabella's letter, which was later released by the White House, states that "bilateral lower extremity venous Doppler ultrasounds were performed and revealed chronic venous insufficiency, a benign and common condition, particularly in individuals over the age of 70."
The examination came after Trump had "noted mild swelling in his lower legs" over recent weeks, Leavitt said.
"Importantly, there was no evidence of deep vein thrombosis (DVT) or arterial disease", and Trump's lab testing was all "within normal limits," according to the letter.
Trump also underwent an echocardiogram.
"No signs of heart failure, renal impairment, or systemic illness were identified," Barbabella wrote.
Chronic venous insufficiency is a condition in which valves inside certain veins don't work the way they should, which can allow blood to pool or collect in the veins. About 150,000 people are diagnosed with it each year, and the risk goes up with age.
Symptoms can include swelling in the lower legs or ankles, aching or cramping in the legs, varicose veins, and pain or skin changes. Treatment may involve medication or, in later stages, medical procedures.
A woman wears Donald Trump leggings on 19 January 2025 in Washington, DC.
Photo:
Christopher Furlong / Getty Images / AFP
"It's basically not alarming information, and it's not surprising," Dr Jeremy Faust, an assistant professor of emergency medicine at Harvard Medical School, told CNN.
"This is a pretty normal part of aging, and especially for someone in the overweight to obese category, which is where the president has always been.
"But the bigger concern … is that symptoms like this do need to be evaluated for more serious conditions, and that is what happened."
Chronic venous insufficiency can be related to conditions like increased pressure from the heart or sleep apnea, cardiologist Dr Bernard Ashby told CNN.
"Even though he's diagnosed with a benign condition, venous insufficiency, by itself, doesn't necessarily mean it's benign. The question is, what's causing the venous insufficiency?
"And so I would want to know whether or not he has any evidence of, again, increased pressures in the heart or increased pressures in the lungs, which can be contributing to that, and if so, what is the primary cause of that?"
Trump's doctors were "covering all their bases" by screening him for heart failure, increased pressure and other conditions, he said.
Age, obesity and inactivity can all lead to the condition.
"If a person is older, a person is overweight, a person is not engaging in regular physical activity or exercise, if a person is sitting or standing for prolonged amounts of time, you can get chronic venous insufficiency," Dr Chris Pernell told CNN.
"And while it is not life-threatening, it can be debilitating," she added.
Leavitt later added that the president was experiencing "no discomfort."
The press secretary also addressed bruising that has appeared on the back of the president's hand, which she attributed to his "frequent handshaking," plus his use of aspirin.
"This is consistent with minor soft tissue irritation from frequent handshaking and the use of aspirin, which is taken as part of a standard cardiovascular prevention regimen," Barbabella's letter said.
The letter concludes that "President Trump remains in excellent health."
Trump will become the nation's oldest president during his second term.
-CNN
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
1News
2 days ago
- 1News
Trump loves cane sugar in his Coca-Cola – is it better for you?
President Donald Trump teased the announcement last week, but now the Coca-Cola company has confirmed it: a cane sugar-sweetened version of the beverage maker's trademark soda will be released in the US this year. For decades, Coke and the makers of other soft drinks have generally used high fructose corn syrup or artificial sweeteners in their products manufactured in the US. But American consumers are increasingly looking for food and drinks with fewer and more natural ingredients, and beverage companies are responding. The Royal Society says in New Zealand, sucrose - derived from cane sugar - is the most common sweetener in fizzy drinks, unlike the US where high-fructose corn syrup is more prevalent. PepsiCo and Dr Pepper have sold versions of their flagship sodas sweetened with cane sugar in the US since 2009. Coca-Cola has sold Mexican Coke — which uses cane sugar — in the US since 2005, but it's positioned a trendy alternative and sold in glass bottles. Coke with cane sugar will likely be more widely available. Here are some frequently asked questions about the sweeteners in US sodas: ADVERTISEMENT What's the difference between cane sugar and high fructose corn syrup? Many consumers know that consuming too many sweets can negatively affect their health, but soda drinkers sometimes debate if either cane sugar or high fructose corn syrup is better (or worse) than the other. The short answer is that it doesn't make a difference, said Marion Nestle, one of the nation's top nutrition experts and professor emeritus at New York University. High fructose corn syrup is made of the simple sugars glucose and fructose in liquid form. Cane sugar, also known as sucrose, is made of glucose and fructose bonded, but quickly split, Nestle explained. Both are still sugars, with about the same amount of calories. Whether a can of Coca-Cola contains one or the other, it will still be a sugary drink with about the same amount of calories and the same potential to increase well-documented health problems from obesity and diabetes to tooth decay. Why did soda companies switch from using sugar to high fructose corn syrup? ADVERTISEMENT ottles of Mexican Coca-Cola are displayed at a grocery storeottles of Mexican Coca-Cola are displayed at a grocery store (Source: Associated Press) High fructose corn syrup costs less. According to price data from the US Department of Agriculture, the wholesale price of HFCS-55, the type of corn syrup most commonly used in beverages, averaged US49.4 cents (NZ82 cents) per pound last year. The average wholesale price of refined cane sugar was US60.1 cents (NZ$1) per pound, while the average wholesale price of refined beet sugar was US51.7 cents (NZ85 cents) per pound. But high fructose corn syrup has advantages beyond price. According to a 2008 paper in the American Journal of Clinical Nutrition, high fructose corn syrup is more stable than sugar when added to acidic beverages, and it can be pumped directly from delivery trucks into storage and mixing tanks. Why is high fructose corn syrup less expensive that sugar? Tariffs are one reason. The US has had barriers on sugar imports almost back to its founding; the first went into place in 1789, according to the Cato Institute, a think tank that advocates free markets. Since the passage of the Farm Bill in 1981, the US has had a system in place that raises duties on sugar once a certain amount has been imported. The US also has domestic production controls that limit supplies, keeping prices higher. But high fructose corn syrup is also cheaper because of the federal government's billions of dollars in subsidies for corn farmers. Loans, direct payments, insurance premium subsidies and surplus crop purchases all lower farmers' costs – and the price of the corn they grow. ADVERTISEMENT Are sugar replacements used in diet sodas safe? Bottles of Coca-Cola are displayed at a grocery store in Mount Prospect (Source: Associated Press) While cutting back on added sugars has documented benefits, replacing them with artificial sweeteners is complicated, too. Coca-Cola Zero Sugar, introduced in 2017, uses the artificial sweetener aspartame and the natural sweetener stevia in its recipe. But research suggests that aspartame may be linked to cancer. In 2023, a committee for the World Health Organisation determined that aspartame should be categorised 'as possibly carcinogenic to humans'. While that doesn't mean that diet soda causes cancer, the scientific committee concluded that there may be a possible link between aspartame and liver cancer, and that the issue should be studied further. The US Food and Drug Administration disagreed with the WHO panel, citing 'significant shortcomings' in the research that backed the conclusion. ADVERTISEMENT FDA officials noted that aspartame is one of the most studied food additives and said 'FDA scientists do not have safety concerns' when it is used under approved conditions. Stevia, a plant-based sweetener, appears to be 'a safe choice', according to the Center for Science in the Public Interest, an advocacy group. - with
Otago Daily Times
3 days ago
- Otago Daily Times
Telehealth launch criticised
A local primary health organisation has criticised recent announcements about the launch of telehealth services. Minister of Health Simeon Brown recently announced a new 24/7 digital health service offering virtual consultations with New Zealand-registered doctors and nurses "anytime, anywhere". The service connects patients to clinicians through trusted providers using secure digital technology. Doctors and nurse practitioners will be able to assess symptoms, diagnose conditions, prescribe medications and provide referrals — all from wherever the patient is. "This is about making sure Kiwis can get the medical help they need when they need it, especially when they can't get a timely appointment with their regular general practitioner, or outside normal clinic hours," Mr Brown said. "It also helps ease pressure on emergency departments by treating non-urgent issues earlier and in the right setting." It would ensure care was available when and where it was needed, helping to bridge the gap when traditional access to a general practitioner was not possible, he said. The digital service gave people greater access to the care they needed, but did not replace the critical role of general practitioners, who were responsible for their patients' continuity of care. "That is why providers will be required to send clinical notes back to a patient's GP after an appointment. "At the same time, we are backing GPs with a record up-to-14% funding boost this year to support the critical work they do in our communities," Mr Brown said. WellSouth chief executive Andrew Swanson-Dobbs said primary care was in crisis in many parts of the Southern region and across the country. "We continue to hear about clinicians working unpaid, about doctors unable to retire as there is no replacement." "This is compounded in our rural parts," Mr Swanson-Dobbs said. About half of the general practices in Otago and Southland are rural or at least a 50-minute drive from a hospital. Existing services had been undermined, both clinically and financially, by telehealth providers, he said. "Investment is shifted to a service that effectively takes patients away from their own GPs. "To make matters worse, telemedicine is pulling GPs and nurses from practices for these telehealth roles." Telehealth was contributing to the issue and should not be seen as an alternative to a superior face-to-face service, he said. "If you want to reverse the trend of too few GPs, hire more GPs, fund the existing GPs adequately." As the primary health organisation for Otago and Southland, WellSouth had always maintained that investment in primary care should first and foremost support the workforce on the ground in existing general practices. "Our rural communities especially need clinicians to keep their practices sustainable." While telemedicine was an important part of primary care, more investment in people was needed, he said. "That is why at WellSouth, we are investing in building and sustaining our local general practice workforce, through new investment in training and supporting our GP registrars and new nurse practitioners, in addition to our existing nursing workforce and healthcare assistants." Mr Brown said that, as minister of health, his priority was to ensure all New Zealanders had access to timely, quality healthcare. "That is why the government has invested a record $16.68 billion in health over three budgets to bring down wait lists, employ more frontline health workers and ensure we have the health infrastructure Kiwis need. "This government has been clear that we want to see more healthcare delivered in the community and ensure that hospitals have capacity to provide planned treatments and emergency procedures. "To do this, we need greater funding of primary and community healthcare." The recent announcement of an agreement between the government and the University of Waikato to establish a new medical school may provide some welcome news. WellSouth clinical director Dr Carol Atmore said training doctors with a focus on primary care and rural health was important for the country. "The evidence shows that if you train people from rural backgrounds in rural settings both at undergraduate level and once qualified as doctors, those doctors are much more likely to settle and work in rural communities in the longer term. "Nearly half of our communities in Otago and Southland are rural and this is where the biggest workforce issues sit across the country." While there was no guarantee the graduates would end up working in the South, it was hopeful that having about 120 graduates going through the new primary care and rurally focused training programme at the University of Waikato might help alleviate some of those workforce pressures for Otago and Southland in the long term, Dr Atmore said.
RNZ News
3 days ago
- RNZ News
US-funded contraceptives for poor nations to be burned in France, sources say
By Ammu Kannampilly , Jennifer Rigby and Jonathan Landay , Reuters The logistics warehouse in Geel, Belgium, where millions of condoms and other contraceptives have been stored by the US development agency USAID. Photo: LUC CLAESSEN / Belga / AFP US-funded contraceptives worth nearly $10 million are being sent to France from Belgium to be incinerated, after Washington rejected offers from the United Nations and family planning organisations to buy or ship the supplies to poor nations, two sources told Reuters. The supplies have been stuck for months in a warehouse in Geel, a city in the Belgian province of Antwerp, following President Donald Trump's decision to freeze US foreign aid in January. They comprise contraceptive implants and pills as well as intrauterine devices to help prevent unwanted pregnancies, according to seven sources and a screengrab shared by an eighth source confirming the planned destruction. The US government will spend $160,000 (about NZ$265,000) to incinerate the stocks at a facility in France that handles medical waste, according to four of the sources with knowledge of the matter, following Trump's decision to shut down the US Agency for International Development (USAID). The US State Department did not respond to a request for comment on the negotiations to save the contraceptives from destruction or the plans to incinerate them. US lawmakers have introduced two bills this month to prevent the destruction of the supplies but aid groups say the bills are unlikely to be passed in time to stop the incineration. The Belgian foreign ministry said Brussels had held talks with US authorities and "explored all possible options to prevent the destruction, including temporary relocation". "Despite these efforts, and with full respect for our partners, no viable alternative could be secured. Nevertheless, Belgium continues to actively seek solutions to avoid this regrettable outcome," it said in a statement shared with Reuters on Tuesday. "Sexual and reproductive health must not be subject to ideological constraints ," it added. The supplies, worth $9.7 million (NZ$16.07m), are due to expire between April 2027 and September 2031, according to an internal document listing the warehouse stocks and verified by three sources. Sarah Shaw, Associate Director of Advocacy at MSI Reproductive Choices, told Reuters the non-profit organisation had volunteered to pay for the supplies to be repackaged without USAID branding and shipped to countries in need, but the offer was declined by the US government. "MSI offered to pay for repackaging, shipping and import duties but they were not open to that... We were told that the US government would only sell the supplies at the full market value," said Shaw. She did not elaborate on how much the NGO was prepared to pay, but said she felt the rejection was based on the Trump's administration's more restrictive stance on abortion and family planning. "This is clearly not about saving money. It feels more like an ideological assault on reproductive rights, and one that is already harming women." She added that many countries in sub-Saharan Africa had relied on USAID for access to contraception and that the aid cuts would lead to a rise in unsafe abortions. The United Nations' sexual and reproductive health agency, UNFPA, also offered to buy the contraceptives outright, three sources told Reuters, without disclosing the financial terms of the proposal. However, negotiations broke down, a source with knowledge of the talks said, in part due to a lack of response from the US government. UNFPA declined to comment. One of the sources with knowledge of the issue said that the Trump administration was acting in accordance with the Mexico City policy, an anti-abortion pact in which Trump reinstated US participation in January. The pact forbids the US government from contributing to or working with organisations providing funding or supplies that offer access to abortions. The source said there was no way for the US government to ensure that UNFPA would not share the contraceptives with groups offering abortions, violating the Mexico City policy. The source also said the matter was complicated by the fact that the contraceptives in Belgium were embossed with the USAID trademark and Washington did not want any USAID-branded supplies to be rerouted elsewhere. UNFPA did not immediately respond to requests for comment on the concerns raised by the source. MSI, which says on its website that it fights for a future where everyone can access contraception and abortion, accused the State Department earlier this month of being "hellbent on destroying life-saving medical supplies, incurring additional costs for the US taxpayer in the process." The State Department declined to comment. Abortion is a divisive issue in US politics and was a major issue in the 2024 election won by Trump. In 2022, the US Supreme Court ruled to eliminate a nationwide right to abortion, leaving abortion laws to each of the 50 states. One of the two sources who told Reuters the stocks of contraceptives were being trucked to France said it would likely take dozens of truckloads and at least two weeks to move the supplies out of the Geel warehouse, with a third source also confirming the scale of the operation. The French government did not immediately respond to requests for comment. Chemonics, the contractor managing the supply chain for USAID's family planning programme, declined to comment on the plans to destroy the supplies. An internal USAID memo, sent in April, said a large quantity of contraceptives was being kept in warehouses and they should be "immediately transferred to another entity to prevent waste or additional costs". - Reuters
